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SUPPLEMENTARY NOTES
Original contains color plates. All DTIC reproductions will be in black and white. Our knowledge of the transformation process has emerged largely from studies of primary rodent cells and animal models. However, numerous attempts to transform human cells using oncogene combinations that are effective in rodents have proven unsuccessful. These findings strongly argue for the study of homologous experimental systems. Here we report that the combined expression of adenovirus E IA, Ha-RasV 12, and MDM2 is sufficient to convert a normal human cell into a cancer cell. Notably, transformation did not require telomerase activation. Therefore, activation of telomere maintenance strategies is not an obligate characteristic of tumorigenic human cells.
Activation of telomerase, and consequently telomere maintenance, is a common characteristic of human tumors. Existing models of human cancer cells, created by the introduction of defined genetic alterations, all include telomerase activation as an obligate component of the transformed phenotype. Here we demonstrate that normal human cells can be converted into cancer cells, capable of forming tumors in immunocompromised mice in the absence of telomerase activation or an alternative telomere maintenance strategy. This suggests that alterations in telomere biology must be viewed similarly to genomic instability as catalysts of transformation rather than as central components of the transformed phenotype.
INTRODUCTION
Much of what we know about the details of neoplastic transformation comes from studies in cell culture. With the original demonstration by Weinberg, Wigler, and Barbacid that rodent cells could be transformed in vitro by DNA sequences from cancer cells, laboratory mouse strains and resultant cell lines have become premier models for the study of oncogene and tumor suppressor function. This has evolved in recent years to the study of genetically defined mouse cancer models, both transgenics and knock-outs. These have provided a great deal of key information regarding the transformation process and have served as model systems in which to test new anti-cancer therapies. Despite the utility of the aforementioned approach, there is a fundamental problem with absolute reliance on this paradigm. Genetic alterations that easily transform rodent cells in culture do not have a similar effect on normal human cells. This implies an inherent difference between the processes of neoplastic transformation in man and mice. In the face of intense scrutiny, the nature of this difference has remained a mystery for more than 30 years.
One distinguishing feature of primary rodent cell cultures is that they can be easily immortalized (Blasco et al., 1997a) . Human cells, in contrast, rarely undergo spontaneous immortalization (Imam et al., 1997) . This almost certainly reflects a difference in the mechanisms by which replicative lifespan is extended. In mouse cells, inactivation of the p53 pathway is sufficient for immortal growth, perhaps indicating that a damage response limits proliferation, whereas the process in human cells is much more complex . This most likely reflects a physical limitation on the proliferation of primary human cells that is imposed by their shorter telomeres and a profound lack of telomerase. This observation is further bolstered by the fact that the activation of telomerase is sufficient to immortalize primary human fibroblasts in culture (Counter et al., 1998) .
Recent reports from the Weinberg lab (Hahn et al., 1999; Elenbaas et al., 2001; Lundberg et al., 2002) indicated that telomerase expression may serve as the critical difference between transformation of mouse and human cells. In these studies, it was shown that the telomerase catalytic subunit, hTERT, could cooperate with combined expression of the SV40 early region and activated Harvey Ras (V12) to transform primary human cells. Our data, however, indicate that this is not keystone to transformation of all cell types. Instead, we have shown that primary human fibroblasts can initially undergo transformation in the absence of telomerase and that telomerase activation typically occurs in the latter stages of tumorigenesis .
This work has provided important information regarding our understanding of the initiation and development of human cancers. Chiefly, this work has resulted in a minimal formula for transforming primary human diploid fibroblasts and human mesodermal cells. These experiments have also provided an opportunity to examine the precise combination of cellular pathways that must be altered in order to result in transformation. An additional benefit is that these cells engineered with precise genetic alterations serve as powerful tools for testing drug therapies, both in vitro and in xenograft models.
Ultimately, our understanding of a cancer cell serves two purposes. First, the study of transformation pathways has and will continue to yield important information SEGER DAMD 17-01-1-0210 regarding how normal cells regulate growth and proliferation. Second, only through understanding the precise molecular events that are required to generate a human tumor may we hope to design rational and specific therapies to battle human cancers. SEGER DAMD 17-01-1-0210
BODY
The field of cancer biology continues to grow and evolve through the development of new molecular tools and mouse model systems that are used to enhance our understanding of how oncogenes and tumor suppressors work within biological systems to promote tumorigenesis. Cell culture experiments utilizing both human and rodent cells have served as one of the central approaches to determining how these molecular networks interact during tumorigenesis, however, one must also note that these systems are not always directly comparable or fully representative of physiological conditions. One key example of such a mouse versus human difference is the number of genetic alterations required to convert a normal cell into a cancer cell. While rodent cells can be transformed by two genetic "hits," such as SV40 Large T-antigen or adenoviral EIA in combination with constitutively activated ras Ruley, 1983) , human cells cannot be transformed by these combinations, indicating that the pathways involved in transformation may differ between mouse and human.
A significant and notable difference between rodent and human cells is the requirement for telomerase, the enzyme responsible for maintaining the ends of chromosomes, known as telomeres, during DNA replication. While rodent cells have constitutive activation of the telomerase enzyme in both somatic and germ cell lineages, human cells only have expression in germ cells (reviewed in McEachern et al., 1994) . Interestingly, the majority of human tumors are telomerase positive , indicating a potential role for telomerase activation in tumorigenesis. In a series of publications, Weinberg and colleagues have shown that primary human fibroblasts, mammary epithelial, and small airway epithelial cells can be transformed by coexpression of the SV40 early region (large T-antigen and small t-antigen), the catalytic subunit of telomerase, hTERT, and a constitutively activated form of Harvey Ras (V12) (Hahn et al., 1999; Elenbaas et al., 2001; Hahn et al., 2002; Lundberg et al., 2002) .
While the majority of human cancers indicate increased ras expression (typically through an activating mutation), recapitulation of this event has proven difficult in both rodent and human primary cell culture systems, as ras overexpression initiates a severe and irreversible growth arrest program called senescence (Serrano et al., 1997) . While several proteins have been shown to bypass ras-induced senescence in primary mouse embryonic fibroblasts (E1A, Bmi-1, Tbx-2, and DRILl) (Serrano et al., 1997; Jacobs et al., 1999; Jacobs et al., 2001; Peeper et al., 2002) , only the adenoviral oncoprotein EIA has been shown to be effective of bypassing this effect in primary human fibroblasts (Serrano et al., 1997) . It is also interesting to note that primary human skin fibroblasts (BJ, WI-38, DET551, and HS68) co-expressing E1A and Ha-RasVl2 are capable of in vitro transformation in an assay for anchorage-independent growth . These EIA + Ras expressing cells, however, do not result in tumorigenesis in immunocompromised mice, and require a third genetic alteration, overexpression of MDM2, to result in in vivo transformation .
In the first year report for this project, results pertaining to the characterization of the E1A + MDM2 + Ha-RasV12 model of human cell transformation (Task #1) were outlined. These results culminated in a peer-reviewed publication in November 2002. In the second year report, we began to focus on a series of experiments that examined the functional interactions required for E1A-mediated transformation processes. These SEGER DAMD 17-01-1-0210 experiments were conducted in a two-pronged manner.
The first series of experimentation focused upon testing the ability of a small subset of genes to complement and rescue transformation defects of specific EIA functional mutants. The second approach was to screen a library of genes represented by short-hairpin RNA constructs (shRNAs) for gene silencing capable of complementing this same battery of EIA functional mutants. In this final report, I will present some of the preliminary data in these shRNA complementation experiments that will serve as the basis of continued work on human cell transformation models.
TASK #1: MODELS FOR HUMAN CELL TRANSFORMATION As has been indicated in previous reports for this award (2002 and 2003) , the goals of this task are now complete and resulted in a publication, "Transformation of normal human cells in the absence of telomerase activation" (Cancer Cell 2: 401-413 [2002] ).
The work contained within this task had been the focus of the experiments reported within the 2003 report, and continued to be a focus of experimentation conducted within the final year of this award. The bulk of the data reported in the 2003 report centered upon classical oncogene complementation experiments of two wellcharacterized regions of EIA: the 26-35 region of the N-terminus responsible for binding the transcriptional coactivator family, p400/TRRAP, and the highly conserved Rb binding motif, CR2.
The 26-35 region has been shown to be critical for E1A to interact with the p400 and TRRAP transcriptional coactivators. Interestingly, these coactivators were originally discovered through their interactions with the c-Myc oncogene. Therefore, I tested the ability of c-Myc to rescue the transformation defect of fibroblasts coexpressing EIAA26-35 + Ha-RasV12. As was reported last year, fibroblasts coexpressing E1AA26-35 + cMyc + Ha-RasVl2 are capable of robust anchorage-independent growth in soft agar. The ability of these cells to promote tumorigenic growth in vivo in immunocompromised mice has been tested repeatedly, yielding rather inconsistent results. In some mice, these cells were capable of promoting tumor formation, yet in some rounds of injections, these cells were incapable of promoting tumorigenesis, even after an extended latency. One potential explanation for these mixed results is that perhaps some EIAA26-35 + c-Myc + Ha-RasVl2 expressing cells were sensitized to apoptotic stimuli due to differences in cMyc expression (a constant caveat in utilizing retroviral gene transduction for overexpression experiments), and this hypothesis is currently being tested.
The CR2 region is responsible for binding the RB tumor suppressor, the phosphorylation status of which regulates E2F-mediated transcription, and thus progression of the cell cycle to S phase. The complex of cyclin E and CDK2 is responsible for this hyperphosphorylation status of Rb. Studies of the pathways involved in EIA-mediated apoptosis indicate that EIAACR2 can be functionally complemented cyclin E expression (A. Samuelson and S. Lowe, personal communication.) We therefore SEGER DAMD 17-01-1-0210 tested the ability of cyclin E overexpression to rescue the transformation defect of EIAACR2. Surprisingly, human fibroblasts coexpressing E1AACR2 + cyclin E + HaRasVl2 were capable of relatively normal proliferation, an indication that cyclin E is in fact competent of rescuing the proliferative defect seen in E1AACR2 + Ha-RasVl2 expressing cells. Based upon these results, we therefore tested the ability of cylin E to rescue the EIAACR2 mutation in transformation. Quite strikingly, while E1AACR2 + cyclin E + Ha-RasVl2 indicate a restoration of proliferative capacities, these cells were incapable of promoting anchorage-independent growth in soft agar. These results, as was also indicated in the 2003 report, indicate that while cyclin E expression may be sufficient to rescue the apoptotic pathways of cells expressing EIAACR2, it is not the correct complement for the transformation defects of this mutant.
In addition to the aforementioned classical oncogene complementation assays, this project has also benefited from the studies of RNA interference (RNAi) mechanisms that are currently the focus of the Hannon lab, namely the use of short-hairpin RNAexpressing (shRNA) retroviral vectors. This strategy is a nice complement to the classical oncogene overexpression experiments originally proposed for this project in that we can study both the ability of overexpressed genes to rescue E1A defects and the effect of EIA-target gene silencing on transformation processes. As was indicated in the 2003 report of this project, we had begun testing a series of Rb hairpin constructs for the ability to rescue the proliferation and/or transformation defects of EIAACR2 + Ha-RasVl2. Last year, we reported that the coexpression of a shRNA retroviral construct (kind gift of Masashi Narita, Lowe Lab, CSHL) was capable of rescuing both the proliferative and in vitro transformation defects of the EIAACR2 mutant. One caveat to these experiments is that the levels of Rb suppression by the shRNA constructs would indicate slight variation in each set of experiments. Therefore, the focus of the current work on this project is centered upon minimization of the variations in target gene suppression, and the construction and testing of additional shRNA constructs with different Rb targeting sequences and for additional E1A targets, such as p400, TRRAP and p300. 
CONCLUSION
In conclusion, the work that has been completed since the 2003 report has focused upon testing the ability of shRNA constructs of EIA target genes to rescue the transformation defects of several EIA functional mutants. In the 2003 report, I presented preliminary work that indicated that shRNA constructs for the EIA target gene Rb were capable of rescuing the EIAACR2 functional mutant, restoring both the proliferative capacity and in vitro transformation capabilities of this mutant when coexpressed with Ha-RasVl2. We are currently trying to streamline this shRNA retroviral transduction system to produce gene silencing that is consistent throughout separate experiments. This will also help to provide more consistent in vivo transformation data, although preliminary experiments in immunocompromised mice indicate that cells expressing EIAACR2 + shRNA-Rb + MDM2 + Ha-RasVl2 are capable of promoting tumorigenesis, although a larger data set must be established. In sum, these data indicate that shRNA constructs will be a powerful tool in the analysis of oncogene and tumor suppressor networks and the promotion of tumorigenic phenotype. Yaciuk, P. (1995) . EIA promotes association between p300 and Rb in multimeric complexes required for normal biological activity. J. Virol. 69, 7917-7924.
Whyte, P., Buchkovich, K.J., Horowitz, J.M., Friend, S.H., Raybuck, M., Weinberg, R.A., and Harlow, E. (1988) . Association between an oncogene and an anti-oncogene: the adenovirus EIA proteins bind to the retinoblastoma gene product. Nature. 334, 124-129. Whyte, P., Williamson, N.M., and Harlow, E. (1989 Stevenson and Volsky, 1986; Serrano et al., 1997) . Neoplastic transformation occurs via a series of genetic and Two major hypotheses have emerged as the underlying exepigenetic alterations that yield a cell population that is capable planation for such differences. Primary human and murine cells of proliferating independently of both external and internal sigrespond to oncogene activation via homeostatic mechanisms nals that normally restrain growth. For example, transformed that are proposed to enforce tumor suppression. For example, cells show reduced requirements for extracellular growth proactivation of oncogenes such as c-myc or adenovirus El A sensimoting factors, are not restricted by cell-cell contact, and are tizes primary cells to apoptosis (Debbas and White, 1993 ; Lowe often immortal (Paulovich et al., 1997; Hanahan and Weinberg, et al., 1994; Lowe and Ruley, 1993; Harrington et al., 1994; . Through extensive studies of transformation processes Hermeking and Eick, 1994) . Hyperactivation of the ras oncogene in rodent models, it is known that tumor formation can be or flux through the ras signaling pathway induces a state of terminal growth arrest which is phenotypically similar to cellular achieved by the activation of oncogenes and the inactivation senescence (Serrano et al., 1997) . In murine cells, the latter of tumor suppressor pathways (Paulovich et al., 1997; Hanahan response can be bypassed by genetic alterations, which impair and Weinberg, 2000; Sherr, 1996) . It has long been established the p53 response. Indeed, cells lacking p53 or p19ARF can be that primary rodent cells can be transformed at detectable fretransformed directly by activated ras (Kamijo et al., 1997 ; Serquency by two oncogenic "hits," such as the combination of rano et al., 1996, 1997) . In contrast, inactivation of the p53 ectopic c-myc expression and constitutive activation of Harvey pathway alone is insufficient to rescue human cells from rasRas (Ha-RasV12) Ruley, 1983) . However, induced growth arrest (Serrano et al., 1997) , suggesting that primary human cells have proven to be refractory to transformahomeostatic responses in humans flow through multiple indetion by numerous combinations of cellular and viral oncoprotpendent and redundant effector pathways. eins, indicative of fundamental differences in requirements for A second characteristic that distinguishes primary human transformation in human versus rodent cells (Sager, 1991;  and murine cells is that the latter are easily immortalized (Blasco
SIGNIFICANCE
Activation of telomerase, and consequently telomere maintenance, Is a common characteristic of human tumors. et al., 1997a) . Primary human cells rarely undergo spontaneous the adenovirus oncogene, ElA ( Figure 1A ) (Serrano et al., 1997; immortalization, indicating that the control of cellular lifespan is de Stanchina et al., 1998) . In fact, coexpression of ElA and Hadrastically different between these two cell types (Imam et al., RasV12 provided one of the first demonstrations of transforma-1997; Chin et al., 1999) . This phenomenon can be partially attribtion by cooperating oncogenes in primary rodent cells (Ruley, uted to telomere biology. Unlike the embryonic rodent fibro-1983 ). Therefore, we tested whether combined expression of blasts which have served as common models for studies of ElA and Ha-RasV12 could transform normal human primary transformation in vitro, primary human fibroblasts have relatively fibroblasts. short telomeres and lack detectable telomerase activity (reOne characteristic feature of transformed cells is their ability viewed in McEachern et al., 2000) .
to grow in the absence of anchorage and, therefore, form coloThe importance of telomerase in human tumorigenesis is nies in semisolid media. Early passage normal human foreskin supported by numerous observations. First, the majority of hufibroblasts (designated BJ) expressing ElA or Ha-RasV12 indiman tumors are telomerase-positive . Second, vidually failed to form colonies in soft agar. In contrast, cells telomerase activation is sufficient to immortalize some primary expressing both El A and Ha-RasV1 2 were able to form colonies human cells in culture (Bodnar et al., 1998; Counter et al., 1998;  in soft agar with an efficiency comparable to that seen with transformed human and rodent cells (Figure 1 B) . For human . Third, telomerase is regulated by an oncotasomdhmnadrdn el Fgr ) o ua anget a, 1998).hird, isacte rased is ahighereglated by han onco 293T cells, virtually all plated cells gave rise to colonies, corngene, c-myc, which is activated in a high percentage of human paetoarnef10-3%orBE1NaRsl2(rexm cancrs (ang t al, 198).pared to a range of 10%-30% for BJ/EI A/Ha-RasVl 2 (for examcancrs (ang t al, 198).pie, see Figure 1C ). In general, colonies generated by BJ/ER Previous reports have indicated that primary human fibrope , Re HaF Rare l1 ) contain signif n fewera e l than blasts and epithelial cells can be transformed by a defined comte gener atdb 29 cells iwit in ther bination of genetic elements, comprising the telomerase catalytic subunit, hTERT, the SV40 early region, and Ha-RasV12
The role of EIA in the transformation of primary (Hahn et al., 1999; Elenbaas et al., 2001 . Here human fibroblasts we report an alternative model of human cell transformation. We
ElA is a multifunctional protein that interacts with numerous show that coexpression of two oncogenes, adenovirus El A and cellular proteins involved in controlling proliferation. For examHa-RasV12, is sufficient to enable primary human fibroblasts pie, El A can bind members of the Rb family through conserved to grow in an anchorage-independent manner, a hallmark of in motifs designated CR1 and CR2 (Whyte et al., 1988; Harlow et vitro transformation. However, this combination is insufficient al., 1986; Whyte et al., 1989) . Through these interactions, ElA to promote tumor formation in nude mice. Addition of a third is able to modulate the activity of the E2F family of transcription oncogene, MDM2, can convert these fibroblasts into cells capafactors, thus controlling genes required for entry into S phase ble of forming tumors in vivo. Interestingly, both anchorage- (Wang et al., 1995; Paulovich et al., 1997; Sherr, 1996) . The independent growth in vitro and tumorigenesis in vivo occur in amino-terminus of ElA binds promiscuous transcriptional cothe absence of telomerase activation. Our results indicate that activators, including p300 Wang et al. , while telomerase activation is a common characteristic of hu-1995; Goodman and Smolik, 2000) . The amino-terminus also man tumors, it is not an obligate element of the tumorigenic binds to the protein complex containing p400, a SW12/SNF2 phenotype.
family member, and the c-Myc/pCAF-interacting protein, TRRAP (McMahon et al., 1998; Barbeau et al., 1994 , Fuchs et Results al., 2001 ). This p400 binding region has been shown to be vital for ElA-mediated transformation in mouse cells (Fuchs et al., Coexpression of E1A and Ha-RasV12 permits 2001). The carboxy-terminal region of ElA binds CtBP, a cellular anchorage-independent growth protein, which has been proposed to recruit histone deacety-A defining characteristic of the transformed phenotype is a delases . In order to map the regions and interactions of ElA that are gree of independence from exogenous mitogenic signals. Many essential for its ability to cooperate with Ha-RasV1 2 in conferring of these signals activate the ras pathway, and activating mutaanchorage-independent growth to primary human fibroblasts, tions of ras oncogenes or their upstream regulators often occur we used a series of well-characterized deletion mutants for in in human cancers (Barbacid, 1987; Webb et al., 1998) . However, vitro transformation assays (Samuelson and Lowe, 1997) . Cells in both primary rodent and human cells, expression of the ras were coinfected with Ha-RasV1 2 and mutant El A oncoproteins. oncogene alone results in an irreversible growth arrest that is While a truncated ElA protein consisting of only the aminophenotypically similar to cellular senescence (Serrano et al., terminal 143 amino acids is unable to bind CtBP (Boyd et al., 1997; Lin et al., 1998) . In rodent models, c-myc is capable of 1993; Meloni et al., 1999) , this mutant is capable of cooperating both bypassing ras-induced growth arrest and cooperating with with Ha-RasV12 for colony formation in soft agar with high activated Ha-RasVl12 to transform primary cells into tumorigenic efficiency (Figure 2) . Expression of El A-ACR2, a mutant incapacells . However, combined expression of myc ble of binding pRb (Samuelson and Lowe, 1997) , in combination and activated ras in normal human cells not only fails to result with Ha-RasV12 invariably led to a senescence-like growth arin transformation, but also leads to an accelerated appearance rest. This result indicated that the interaction between ElA and of the senescent-like phenotype (data not shown).
Rb-family proteins is essential for transformation. Loss of the Whereas numerous genetic alterations have been shown to ability to bind p300 also compromised oncogene cooperation, bypass ras-induced growth arrest in murine cells, only very few as did deletion of residues 26-35, indicating that the ability to have been shown to be capable of overriding this response in bind p400 is also critical. Western analysis of ElA mutants normal human cells. One of these is the ectopic expression of (Supplemental Figure S1 at 
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ontent/full/2/5/401/DCl) suggested that each was expressed subcutaneous injection into immunocompromised mice. A total similarly to wild-type, and thus the defects in colony formation of 49 animals were injected in both flanks in a series of five were not due to ElA not being adequately expressed. Expresindependent experiments. Subject mice were either nude, SCID sion of El A-ACR2 mutant was confirmed only in transient infec-(beige), or nude mice that had been irradiated as a mean to tions, since the prevalence of cell death in ACR2/Ras coinfected suppress residual NK (natural killer) responses (Feuer et al., cells prevented the establishment of a stable cell line. Consid-1995) . From a total of 98 injections, only a single tumor formed ered together, these results suggest that El A functions in human in a nude, nonirradiated mouse (Supplemental Table S1 at http:// cell transformation through concerted effects on multiple cellular www.cancercell.org/cgi/content/full/2/5/401/DCl). This tumor pathways that include Rb, p300, and p400.
arose after a substantially longer latency (10 weeks) than is normally observed using control cancer cell lines or transformed EIA + Ha-RasV12-expressing cells fail to form tumors human 293T cells (-2 weeks), suggesting the possibility that a Early and late passage BJ fibroblasts coexpressing ElA and rare additional genetic alteration may have contributed to tumor Ha-RasV12 were tested for the ability to form tumors upon formation in this individual case. Thus, we conclude that while Ha-RasVl2 and assayed tar the ability to form colonies in semisolid media. Only the EIA-143 mutant, which is detective for the ability to bind CtBP, was capable of forming colonies in this assay, indicating that the ability at EtA to bind p300, p400, and Rb is critical for E1A-mediated transformation.
p300
Rb family CtBIP p4OO L the combination of ElA and Ha-RasV12 is sufficient to permit A.
anchorage-independent growth of normal human fibroblasts, this combination is insufficient for tumnorigenesis in nude mice.
EIA, MDM2, and Ha-RasV12 transform normal human cells into tumor cells Previous studies of E1A/Ha-RasV12-mediated transformation in primary mouse embryo fibroblasts (MEF) indicated that transformation mediated by this oncogene combination was much more efficient in the absence of p53 (Lowe and Ruley, 1993) .
In fact, tumors arising from EIA/Ras transformed MEF become apparent only after a long latency period and frequently lack a functional p53 pathway. Interestingly, immunohistochemical analysis of the single tumor produced by the BJ fibroblasts expressing E1A/Ha-RasV12 showed a strong accumulation of nuclear p53; however, results of SSCP analysis excluded the possibility of p53 gene mutations (data not shown). Accumulation of wild-type p53 is a common feature of hu-
B.
man sarcoma, the type of tumor derived from fibroblast precursors. In addition, these tumors often show overexpression of MDM2 (Dei Tos et al., 1997) , indicating that negation of p53 100K function occurs often through mechanisms other than p53 gene 0 mutation. Notably, the tumor that resulted from the ElA/ k8 Ha-RasV1 2-expressing fibroblasts was negative for the expres-4) 60K
0.
sion of pl 9 ARF, an upstream regulator of MDM2 (by immunohistoc 40K chemistry, data not shown), whereas the preinjection population 0 of engineered fibroblasts expressed p19ARF abundantly. Guided 0 20K by these observations, we tested whether negation of the p53 pathway via enforced expression of MDM2 could contribute to the transformation of normal human fibroblasts by ElA and Ha-1-RasVl 2.
-) --3 BJ cells at different passage numbers (see Experimental Procedures for details) were simultaneously coinfected with Figure 3B) . Moreover, the triple-infected cells were able to generate tumors when injected blotting analysis (Supplemental Figure S2 at http://www.cancercell. subcutaneously into immunocompromised in mice ( Figure 4A org/cgi/content/full/2/5/401/DCl). These results argue and Table 1 ). Tumors grew to a size at which the animals had against the possibility of selection for rare genetic events during to be sacrificed within a period of three to six weeks after tumor formation and support the notion that the combined exinjection, a latency comparable to that seen with control human pression of ElA, MDM2, and Ha-RasV12 is sufficient for the cancer cell lines or with transformed 293T cells (Figure 48) . transformation of normal human fibroblasts into tumor cells. Tumor formation was also observed when ElA was substituted by the C-terminal deletion mutant EIA-143 (data not shown).
Human fibroblasts transformed by EIA/MDM2/Ha-RasVl2 Histological and immunohistochemical analyses of ERMlack telomerase activity derived tumors confirmed the human origin of the tumor cell Cell immortalization has been posited as a landmark occurrence population and indicated that the neoplasias have features of in the transformation of a normal cell into a cancer cell. Indeed, sarcoma. Moreover, immunohistochemistry confirmed the most human cancers are telomerase-positive, an indirect indicawidespread and strong expression of ElA, Ras, and MDM2 tion that these cells have acquired a mechanism for both telooncogenes ( Figure 4C) .
mere maintenance and extension of proliferative capacity (Kim Cell populations remained polyclonal throughout drug selecet al., 1994) . In previous reports, transformation of normal hution in vitro and tumorigenesis in vivo, as revealed by Southern man cells absolutely required activation of telomerase via ex-A.
C. Tumors derived from E1A/MDM2/Ha-RasV12 lack pression of the limiting catalytic subunit, hTERT (Hahn et al., telomerase activity 1999; Elenbaas et al., 2001 . We previously Since ERM-engineered fibroblasts were telomerase-negative at showed that ElA, Ha-RasV12, and MDM2 were individually the time of injection into mice, we were curious to ascertain the incapable of activating telomerase in normal human fibroblasts telomerase status of resultant tumors and to determine whether or epithelial cells . We therefore tested the telomerase activation was a requirement for tumorigenesis. Tepossibility that we had transformed normal human cells into lomerase activity was measured utilizing the standard TRAP cancer cells in the absence of telomerase activation, assay described above on tissue sections obtained from the Telomerase activity was easily detected in 293T cells using ERM tumors. Whereas a tissue sample from a human tumor the TRAP assay Wright et al., 1995) . As few produced a robust signal indicative of telomerase activity in a as ten 293T cells were capable of yielding a strong positive TRAP assay, lysates from ERM tumor tissues were telomerasesignal in our assays. As expected, BJ fibroblasts are telomerasenegative ( Figure 5B ). In order to verify that this negative result negative. We similarly fail to detect telomerase activity in BJ was not due to the presence of an inhibitory component within cells that have been engineered to express ElA, Ha-RasV12, the tissue lysate, we performed a mixing experiment with lysate and MDM2 (BJ/ERM) ( Figure 5A ). We conclude that BJ/ERM from 293T cells. When the 293T cell and ERM tumor lysates were cells are telomerase-negative, or contain at least 1000-fold less mixed in a TRAP reaction, the result was positive, indicating that telomerase activity than do 293T cells at the time they are inthere was no inhibitory component within the tumor lysate, and jected into immunocompromised mice.
thus the tumors were below detectable limits for telomerase It is interesting to note that BJ/ERM cells, although able to activity ( Figure 5B ). form colonies in soft agar and tumors in nude mice, are not To verify the forgoing result, we used an independent experiimmortal and, if maintained in culture for an extended period mental strategy. In human cells, and in particular in human of time (40-50 generations), undergo a "crisis phase" characterfibroblasts such as BJ, telomerase activity correlates with the A.
B.
C. as a negative control, B: Tumors were recovered from mice injected Zi with BJ/ERM cells and assayed for the presence of telomerase activity using the TRAP assay. To test whether tissue extracts contained inhibitors of any step of the procedure, we mixed lysate derived from 1,000 telomerase-positive 293T cells with the tumor extract. This produced a positive signal. The figure shows one representative tumor sample. For comparison, a similar telomerase assay performed using a mass-equivalent portion of lysate from a human breast tumor is shown. C: RT-PCR was used to detect hTERT expression in BJ-ERM-derived tumors (tumors 1521, 1662, and 1659: left, sn : right, dx ). Expression was tested by using two primer pairs that would direct the specific amplification of hTERT and not mouse TERT that might be present from contaminating murine cells within the tissue sample. I-actin served as an internal control. Sensitivity of the assay was increased by performing a Southern blot of the PCR reactions for hTERT. 293T, DLD colon cancer, and BL41 lymphoma cell lines were used as positive controls. 293T 1:100 represents the PCR product of 293T cell line diluted 1:100, in order to have an approximate quantification of the signal. The figure shows the result of 40 cycles of amplification for hTERT and 20 cycles for p-actin.
expression of the telomerase catalytic subunit, hTERT (Meyerpresent from contaminating murine cells in the tumor sample. son et al. , 1997; Bodnar et al., 1998) . We used an RT-PCR 13-actin mRNA served as an internal control. Ethidium bromide strategy to search for hTERT expression in BJ/ERM tumor specigel staining showed that hTERT mRNA was easily detectable mens. Expression was tested using two independent primer in RNA derived from human cancer cell lines, but BJ/ERM tupairs that were chosen for their ability to specifically amplify mors were negative ( Figure 5C ). To increase the sensitivity of human TERT without amplifying mouse TERT that might be our assay, we performed Southern blots of the PCR reactions. After Southern analysis, one out of six tumors analyzed, sample 1659sn, showed weak hTERT expression. This signal was detectable only with an exposure at which the signal of the positive A. B.
control cells had reached saturation. The expression of hTERT in this tumor was independently confirmed by increasing the iJ -_ number of PCR cycles to 50 (see Figure 9B ). Considered to- neered to express oncogenes and were passaged in vitro to an The karyotypes of explanted BJ/ERM cells reveal average of 5 kb at passage 20 and 3.1 kb in BJ/ERM after crisis chromosomal abnormalities characteristic occurred in vitro. Consistent with an apparent lack of a telomere of telomere depletion maintenance strategy, telomere depletion continued during tuAs noted above, BJ cells are engineered to express ElA, Hamor formation in vivo such that explanted cell cultures had RasV12, and MDM2 through simultaneous coinfection. Since extremely short telomeres, averaging 1.6 kb with 18% of chrothese cells have not undergone prolonged expansion in the mosome ends lacking detectable telomeric DNA (Figure 7) . presence of any individual oncogene in culture, it is not surprisThese results rule out the possibility that BJ/ERM tumors have ing to find that the karyotypes of the engineered cells are normal amainprior to injection into mice (Supplemental Figure S3A at http:// activated the recombination-based pathways of telomere 1997; www.cancercell.org/cgi/content/full/2/5/401/DC1). Examinatenance (ALT) (Dunham et al., 2000;  tion of cells that are explanted into culture following tumor for- Hoare et al., 2001; . Interestingly, cells exmation, however, reveals numerous chromosomal abnormalities planted from ERM tumors that had become telomerase-positive (Figure 8 , Supplemental Table S2 , and Supplemental Figure in vitro ( Figure 6A ) maintained their ability to form tumors in S3B). In virtually every metaphase, we noted the presence of nude mice and did so at rates similar to those observed for dicentric chromosomes lacking telomeres at the fusion point primary ERM cells (data not shown).
that apparently formed via end-to-end fusion of TTAGGG- B.
ERM P.C.
Translocation
Tricentric Dicentric depleted telomeres. In some metaphases, we also find ring pendent growth and tumor formation (see Experimental Procechromosomes (Supplemental Figure S3B ). In addition, these dures for details). In all the conditions tested, both early and cells showed a very marked aneuploidy as indicated by aberrant late passage BJ/ERM invariably produced colonies in soft agar number of chromosomes in more than 50% of the metaphases and tumors in immunocompromised mice. analyzed, also in agreement with aberrant mitosis as a conseFinally, to verify that E1A/MDM2/Ha-RasV12-mediated quence of severe telomeric dysfunction (Figure 8 ). These types transformation is not unique to BJ fibroblasts, we assessed the of genetic abnormalities are a characteristic outcome of telovalidity of our transformation model in several additional human mere depletion and are similar to those seen in the karyotypes primary fibroblasts, including HSF43, WI-38, Detroit 551, and of Terc-I-mice (Blasco et al., 1997b; Nanda et al., 1995) . Con-SF68 as well as in human primary mesodermal cells, HMSC. sidered together, the results of telomerase detection assays, Upon coexpression of El A/MDM2/Ha-RasVl 2, all were capable telomere restriction fragment analyses, and cytogenetic examiof anchorage-independent growth in soft agar (not shown). Efnation of explanted tumor cells strongly suggest that combined ficiencies of colony formation and rates of colony growth were expression of El A, Ha-RasV12, and MDM2 is capable of transsimilar to those seen with BJ/ERM cells. Furthermore, these forming normal human cells into human tumor cells in the abtriple-infected fibroblasts were capable of tumor formation when sence of direct telomerase activation or alternative mechanisms injected into immunocompromised mice (Table 1 and Figure  of telomere maintenance. 9A). Similar to BJ/ERM, HSF43/ERM, WI-38/ERM, and DET551/ ERM fibroblasts were telomerase-negative and the majority of Multiple human primary fibroblasts can be transformed the tumors derived from these cells failed to show telomerase by coexpression of EIA/MDM2/Ha-RasVl2 expression by hTERT-RT-PCR analysis. Only 2 out of 8 tumors In order to ascertain whether the transforming potential of the tested showed a faint hTERT band following 50 cycles of ampli-ERM combination relied on the relatively long telomeres found fication ( Figure 9B ). This confirms that also in HSF43, WI-38, in early passage BJ fibroblasts, populations of cells at different and DET551 fibroblasts, the ERM combination does not require passage numbers were infected and tested for anchorage-indetelomerase activation to confer tumorigenic potential.
A. 
Discussion
One striking difference between our results and those reported previously is that in our transformation model, we find Primary rodent cells and animal models have made invaluable no requirement for telomerase activation to achieve either ancontributions to our understanding of neoplastic transformation chorage-independent growth in vitro or tumor formation in vivo. and of the biology of oncogenes and tumor suppressors. HowIn fact, consistent with their lack of telomerase or other telomere ever, it is clear that these models do not perfectly recapitulate maintenance strategies, our in vitro-engineered tumor cells the process of tumor development in humans. An early indicashow continuous erosion of telomeric repeats. This ultimately tion of this fact was the inability of human cells to become leads to genetic instability that is typified by our observation of transformed by the same combinations of oncogenes that could numerous chromosome end-to-end fusions and pronounced transform a variety of normal rodent cells. Recently, the ability aneuploidy in cells explanted from tumor tissue. to elicit transformation via specific genetic manipulations was
The majority of human cancer cells are reported to be teloextended to normal human cells (Hahn et al., 1999; Elenbaas merase-positive (Kim et al., 1994) , and this is long been considet al., 2001 considet al., , Hahn et al., 2002 . This has created the opportunity ered a strong indication that the ability to maintain telomeres for the development of a variety of defined human cancer modis an important step in the development of human cancer. Howels to be used for a detailed study of the cellular pathways that ever, it is still debated whether the widespread presence teloare required for the transformation of normal human cells, and merase activity in human tumors is a reflection of a selective ultimately, to an understanding of any differences in requireexpansion of a telomerase-positive stem cell or a selection for ments for the transformation of human cells versus those of a mechanism of telomere maintenance during cancer promodel organisms. Such information could provide critical ingression. sights as rationally designed anticancer therapies move from Our results are consistent with a model in which telomere successful applications in animal models to use in humans.
maintenance is not essential for transformation, per se, but Here we report that primary human fibroblasts can be transinstead serves as a catalyst of tumorigenic conversion and tuformed into cancer cells by combined expression of the adenomor progression. Mouse models have shown that alterations in virus ElA, Ha-RasV12, and MDM2. As in previous models of telomere biology may contribute to tumorigenesis in two ways. human cell transformation, we make use of a combination of viral We and others have previously reported that telomere shortenand cellular oncoproteins that act in a transdominant fashion to ing triggers growth arrest and/or apoptosis, as well as chromoalter cellular physiology and achieve tumorigenic growth. In somal end-to-end fusions, leading to premature aging phenoaccord with previous reports, we show that transformation retypes in the context of the telomerase-deficient mice. These quires negation of both the Rb and p53 tumor suppressor pathphenotypes can be rescued by telomerase activation (Lee et ways. Through genetic analyses, we have also identified requireal., 1998; Herrera et al., 1999 Herrera et al., , 2000 Samper et al., 2001) . Thus, ments for interaction with p300 and p400. Both of these cellular telomere shortening during the presumably prolonged course proteins are also targeted by SV40 large T-antigen, which is a of natural tumor development may antagonize tumorigenesis. critical element of the transformation model reported by WeinIndeed, Terc-1-mice are more resistant to chemical carcinogenberg and colleagues (Hahn et al., 1999; Elenbaas et al., 2001) . esis and to spontaneous tumor development in both p16/ However, recent reports suggest that these are not critical funcp19ARF and APCm"i mutant backgrounds (Greenberg et al., tions of large T, at least in the presence of small t-antigen (Hahn 1999; Gonz~lez-Suarez et al., 2000; Rudolph et al., 2001) . Howet al., 2002) .
ever, exhausted telomeres can also compromise chromosome integrity. In fact, in a p53 1-background, Terc-' mice show Cells infected at passage 16 were injected at passage 25 and 30, while cells higher levels of chromosomal instability and a higher incidence infected at passage 22 were injected at passage 25 and 33. WI-38 are normal embryonic lung fibroblasts (ATCC catalog CCL-75). These cells have a finite lifespan of 50 -_ 10 PD and were provided by ATCC as a prooncogenic factor under certain conditions (Chin et al., at PD24. These cells were infected at passage 6 and 10 and injected into 1999).
mice at passage 14, 15, and 18.
The data presented here suggest that, while changes in Detroit 551 are normal human fetal fibroblasts telomere biology are very likely to be important for the course provided by ATCC around PD 10 and reported to have a finite lifespan of of natural tumor development, telomere maintenance is not an 25 additional serial passages. These cells were infected at passage 6 and 10 and injected into mice at passage 14-15 and 18.
absolute requirement for the creation of human cancer cells by HSF43 are normal human foreskin fibroblasts originally isolated at the acute alteration of oncogenes and tumor suppressors. Rather, Los Alamos National Laboratory. The original PD of these cells was unknown in our human transformation model, the activation of telomere but in our hands they cease proliferation after 40-50 passages. These cells maintenance strategies becomes important only during prowere infected at passage 17 and 20 and injected at passage 24 and 27. longed expansion of tumor cells to restore genomic stability to HS68 are normal human foreskin fibroblasts (ATCC catalog CRL-1 635) an extent that permits cell survival. Our data are in agreement that were received from ATCC at PD 16. These cells can be propagated for 40-50 passages. They were infected at passage 11 and 17.
with observations in a number of human cancers where the HMSC 7214 are normal human mesenchymal stem cells obtained from frequency and intensity of telomerase activation correlates with Poietics-Biowhittaker at passage 2 (catalog PT-2501). They were derived tumor grade/stage (Chadeneau et al., 1995; Hiyama et al., 1995;  from a 19-year-old Caucasian male and their lifespan has not been deter- Albanell et al., 1997; Tang et al., 1998; Ebina et al., 1999 Using oncoprotein mutants and genetic complementation, we find that inactivation of the Rb and p53 tumor suppressor Retroviral infection pathways is critical for this transformation process. FurtherpBABE-Puro Ha-rasV12, Wzl-Neo ElA 12s, pHygroMaRX mdm2, and corremore, we find that the ability of ElA to target p300 and p400 sponding empty retroviral vectors were used to singularly transfect the amis essential for its ability to function as a human oncogene. It photropic packaging cell line LinX-A (Hannon et al., 1999) . Transfection was performed by the calcium phosphate method. At 72 hr posttransfection, will also be of interest to determine whether MDM2 contributes viral supernatants were collected, filtered, supplemented with 4 pkg/ml polyto the transformation of human cells solely through its ability brene, and combined in order to obtain the oncogene combinations deto antagonize p53 or also via effects on additional cellular pathscribed in the text. In cells where only one or two oncogenes were used to ways.
infect the primary cells, corresponding empty vectors replaced the omitted
The war on cancer is predicated on the notion that increased oncogenes so that infected cells were equally resistant to all the selection drugs used (hygromycin, puromycin, and neomycin). The proper viral mix was then used to infect human primary fibroblasts (BJ, Detroit 551, Wl-38, "Achilles heel" that can be exploited as an effective and specific HSF43, SF68) and human primary mesodermal cells (HMSC) . After infection, therapeutic target. The use of rodent cell culture and of animal cells were selected with a combination of hygromycin (50 gg/ml), puromycin models have been the most informative vehicles in the drive (1 lig/ml), and neomycin (300 jig/ml) for 7 days. Effective infection was toward this goal. However, the availability of defined human cell confirmed by Western blot analysis. transformation models will allow us to build toward a complete Western blot analysis understanding of the biological pathways that must be altered
Western blotting was performed essentially as described by Harlow and to achieve tumorigenic conversion of normal cells. Lane (1999) . Cells were washed with cold PBS and lysed in Laemmli loading buffer. Lysates were heated at 95°C for 10 min. Samples were separated on Experimental procedures 10% SDS-polyacrylamide gels and transferred to nitrocellulose membranes (Schleicher & Schuell) . Blots were incubated with the following mouse monoCells clonal antibodies: ElA-specific M58 and M73 antibody-the latter recogThe following human primary cells were used for the experiments described nizes an epitope retained in all E1A mutants studied (Samuelson and Lowe, in the text. We defined passage number 1 as the passage at which the cells 1997); c-Ha-ras (OP23) (Oncogene Research Products); mdm2-spcific antiwere provided from ATCC. All the cells were maintained at a subcultivation body (4B2) (a kind gift from A. Levine); bcl2 (C2) (Santa Cruz); p53 (DO-1) ratio of 1:2 every 3 days.
(Santa Cruz). Immune complexes were visualized by secondary incubation BJ are normal human foreskin fibroblasts (ATCC catalog CRL-2522).
with a sheep anti-mouse HRP-conjugated secondary antibody (Amersham). They were provided by ATCC at population doubling 22 and are described Blots were developed by enhanced chemiluminescence (Amersham). to have the capacity to reach 80 ± 10 PD. In our hands, these cells cease proliferation at around passage 45. Most of the experiments described in Anchorage-independent growth the text were done using BJ infected at passage 16 and injected at passages Human primary fibroblasts uninfected, infected with a control empty virus, 20, 25, and 30. However, experiments were also performed at earlier and or expressing different oncogenes (ElA, Ha-rasV12, mdm2), alone or in later passages. In particular, BJ cells were infected at passage 8, 16, and combination, were analyzed for anchorage-independent growth in semisolid 22. Cells infected at passage 8 were injected into mice at passage 12 and 20.
media. Approximately 101 cells were plated in 0.3% low melting point aga-rose/growth media onto 60 mm dishes with a 0.5% agarose underlay. Fresh
Images were captured using Leica Q-FISH software at 400 mSec intetop agar was added weekly. Colonies were photographed after 2 weeks.
gration-time in a linear acquisition mode to prevent oversaturation of fluorescence intensity and recorded using a COHU CCD camera on a Leica
Subcutaneous tumorigenicity assay Leitz DMRB fluorescence microscope. For the tumorigenicity assays, eight-week-old immunocompromised TFL-Telo software (gift from Dr. Lansdorp, Vancouver) was used to athymic nude mice (Hsd:Athymic nude-nu, Harlan) were used. Cells (5 x quantify the fluorescence intensity of telomeres from at least 10 metaphases 106) were resuspended in 100 gl of PBS and injected with a 25 gauge needle of each data point. The images of metaphases from different cell cultures into anaesthetized mice.
were captured on the same day in parallel, and scored blind. BJ cells infected with the ElA/ras combination were also injected into
Terminal restriction fragment analysis (TRFJ 10 nude mice -y-irradiated with 400 rad prior injection and into 6 SCID beige Cells were prepared in agarose plugs and digested with Mbo I for TRF mice (C.B-17/lcrHsd-scid-bg, Harlan). Tumor size was monitored every 5 analysis using pulse-field electrophoresis as described in Blasco et al. days. Mice were sacrificed when the tumors reached a diameter of 1-1.2 (1997b). cm or after 16 weeks of monitoring.
Telomerase assays Tumors were collected in a sterile field and minced. Tumor fragments Telomerase activity was measured with a modified telomeric repeat amplifiwere immediately frozen in liquid nitrogen for DNA and protein extraction cation protocol (TRAP), as described (Blasco et al., 1997b) . and for telomerase assays. Other fragments were fixed in 10% formalin for histological and immunohistochemical examinations. Finally, fragments were Analysis of hTERT mRNA expression by RT-PCR finely minced, washed in PBS, and plated in culture medium for isolation of Analysis of human TERT expression was carried out by RT-PCR. cDNA was tumor cells, synthesized from 1 p.g of total RNA using random primers in a 20 p. 1 reaction.
1 p. 1 of cDNA was then used to amplify two fragments of human TERT Tumor morphological and histochemical examination sequence, both spanning an intronic sequence. Primers hTERT1 s, 5'-TTCCT Formalin-fixed/paraffin-embedded or snap-frozen fragments of tumor speci-GCACTGGCTGATGAGTGT-3' and hTERT1 a, 5'-AGCGTCGGCCCTCTTTTC mens were stained with hematoxylin and eosin and with histochemical stains TCTG-3' were used to amplify a 330 bp fragment spanning exons 3 and 4 (PAS and PAS after diastase, Reticulum, and Masson's trichrome stain) for of the human TERT sequence. Primers hTERT2s, 5'-ACAGCACTTGAA morphological evaluation and histochemical analyses. Immunohistochemis-GAGGGTG-3' and hTERT2a, 5'-GTGCCTTCACCCTCGAGG-3' were used try was performed with the peroxidase ARK kit (DAKO Glostrup Denmark) to amplify a 210 bp fragment spanning exons 4 and 5 of the human TERT and DAB as chromogen. The following primary antibodies were utilized:
sequence. Both PCR reactions were carried out for 40 or 50 cycles with an Intermediate filaments (Vimentin, pan-keratin, desmin) and other human speelongation at 72'C for 30 s and annealing at 65°C. PCR products were cific monoclonal antibodies (S100 protein, EMA, CD45) were used as histoanalyzed on a 3% agarose gel. The quality of cDNA was controlled by PCR genetic markers. The expression of ectopically expressed oncogenes was amplification of a 500 bp fragment of a P-actin transcript in a 20 cycle-PCR determined by using monoclonal antibodies specific for MDM2 (4B2) (a kind reaction. gift from A. Levine), p21-ras (OP23) (Oncogene Research Products), and ElA (M73). Subcutaneous tumor formation in immunocompromised mice by BJ fibroblasts coexpressing E I A and Ho-RosV 12. BJ fibroblasts coexpressing E IA and Ho-RasV12 were unable to result in tumor formation in nude mice. There was one instance in which a single tumor formed in the flank of a bilaterally injected mouse, which is denoted as I*. This tumor arose after a much greater latency period, indicating the possibility for the selection of a mutation in viva. 
